Traders purchased shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading hours on Monday. $126.55 million flowed into the stock on the tick-up and $86.57 million flowed out of the stock on the tick-down, for a money net flow of $39.98 million into the stock. Of all companies tracked, UnitedHealth Group had the 5th highest net in-flow for the day. UnitedHealth Group traded down ($0.95) for the day and closed at $140.32

Several analysts have issued reports on UNH shares. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $146.00 target price on the stock in a research note on Wednesday, April 20th. Leerink Swann restated an “outperform” rating and issued a $150.00 target price on shares of UnitedHealth Group in a research note on Tuesday, April 19th. Cowen and Company reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, April 5th. Morgan Stanley reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Finally, Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Two analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $146.02.

The firm has a market capitalization of $133.42 billion and a price-to-earnings ratio of 22.56. The company’s 50-day moving average price is $137.80 and its 200-day moving average price is $126.46.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 19th. The healthcare conglomerate reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.09. The business earned $44.50 billion during the quarter, compared to the consensus estimate of $43.96 billion. During the same period last year, the firm earned $1.46 EPS. The business’s quarterly revenue was up 24.5% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Inc. will post $7.89 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Friday, June 17th were issued a $0.625 dividend. This represents a $2.50 annualized dividend and a yield of 1.78%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.50. The ex-dividend date was Wednesday, June 15th.

In other news, Director Gail R. Wilensky sold 5,500 shares of the business’s stock in a transaction on Friday, June 10th. The shares were sold at an average price of $139.80, for a total transaction of $768,900.00. Following the sale, the director now directly owns 59,019 shares of the company’s stock, valued at $8,250,856.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Thursday, June 16th. The shares were sold at an average price of $138.58, for a total transaction of $692,900.00. Following the sale, the director now directly owns 72,229 shares in the company, valued at $10,009,494.82. The disclosure for this sale can be found here.

Other large investors recently made changes to their positions in the company. Investment House LLC raised its stake in shares of UnitedHealth Group by 0.5% in the fourth quarter. Investment House LLC now owns 9,975 shares of the healthcare conglomerate’s stock worth $1,173,000 after buying an additional 50 shares during the period. Argent Trust Co raised its stake in shares of UnitedHealth Group by 0.5% in the third quarter. Argent Trust Co now owns 13,437 shares of the healthcare conglomerate’s stock worth $1,559,000 after buying an additional 65 shares during the period. Mark Sheptoff Financial Planning LLC raised its stake in shares of UnitedHealth Group by 0.3% in the fourth quarter. Mark Sheptoff Financial Planning LLC now owns 36,079 shares of the healthcare conglomerate’s stock worth $4,244,000 after buying an additional 103 shares during the period. Alerus Investment Advisors Corp raised its stake in shares of UnitedHealth Group by 0.4% in the fourth quarter. Alerus Investment Advisors Corp now owns 27,725 shares of the healthcare conglomerate’s stock worth $3,262,000 after buying an additional 109 shares during the period. Finally, Mycio Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 1.5% in the fourth quarter. Mycio Wealth Partners LLC now owns 10,487 shares of the healthcare conglomerate’s stock worth $1,234,000 after buying an additional 150 shares during the period.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.